Trial intelligence / Profile preview

FOCUS trial of fluoxetine after recent stroke

2011-005616-29Phase 3Completed

Sponsor
University of Edinburgh
Start
Jan 2012
Modality
Small Molecules
Countries
1
01

Overview

Phase 3, randomised, double-blind trial in stroke, ischemic stroke and intracerebral hemorrhage (ICH) comparing Fluoxetine with Placebo (2 arms). Primary endpoint: Modified Rankin Scale at 6 months. Started Jan 2012; status: completed.

02

Drugs

fluoxetine
03

Conditions

strokeischemic strokeintracerebral hemorrhage (ICH)

Beyond the preview

Go deeper on 2011-005616-29.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2011-005616-29.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call